WuXi PharmaTech Launches Preclinical Medical Device Testing Services in China
WuXi PharmaTech’s Laboratory Testing Division has launched preclinical medical device testing services in China.
Clinical medical device testing services include biocompatibility, microbiology and chemistry testing services. Major tests being offered include in vitro cytotoxicity, irritation, sensitization, hemocompatibility and implantation.
The services are being offered for Chinese and international clients for product registration with the China Food and Drug Administration, as well as for Chinese clients for product registration in global markets.
WuXi PharmaTech, which has operations in the U.S. and China, is a research and development capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries. — Michael Cipriano